You are viewing: Japan Minimally Invasive Surgery Market analysis

The Japan Minimally Invasive Surgery Market was valued at $5596.3 Million in 2025 and projected to reach to $10382.2 Million by 2030, representing a compound annual growth rate of 13.2%. Japan's minimally invasive surgery market is poised for sustained expansion driven by demographic shifts and technological advancement.

Japan Minimally Invasive Surgery Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 13.2%, reflecting Japan's advanced healthcare infrastructure and aging population driving demand for less invasive surgical procedures.
  • Japan's adoption of cutting-edge surgical technologies and strong reimbursement policies position the country as a key market within the Asia Pacific region. The growth trajectory in Japan is underpinned by increasing prevalence of chronic diseases, rising healthcare expenditure, and a well-established medical device ecosystem.
  • Japan's emphasis on patient outcomes and recovery time reduction has accelerated the shift toward minimally invasive techniques across multiple surgical specialties.
  • Between 2025 and 2030, Japan is expected to see significant investments in surgical innovation and training infrastructure to support market expansion..

Key Market Statistics

  • CAGR (2025-2030) 13.2% CAGR
  • Market Size, 2025 ~USD 5596.3 Million
  • Forecast, 2030 ~USD 10382.2 Million
  • Country Japan

Japan Minimally Invasive Surgery Market Overview

Market Valuation & Growth :

Japan's minimally invasive surgery market is valued at USD 5,596.3 million in 2025, with a projected CAGR of 13.2% through 2030, reaching USD 10,382.2 million. This growth outpaces many developed markets due to Japan's commitment to advanced surgical technologies.

Aging Population Driver :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases demand for minimally invasive procedures that reduce recovery time and surgical complications in elderly patients.

Advanced Healthcare Infrastructure :

Japan's world-class healthcare system, high hospital automation rates, and early adoption of robotic-assisted surgery technologies position it as a leader in minimally invasive surgical innovation in Asia-Pacific.

Technological Innovation Hub :

Japanese manufacturers and healthcare providers are pioneering next-generation endoscopic instruments, laparoscopic devices, and robotic surgery systems, creating a competitive advantage in the regional market.

Japan Minimally Invasive Surgery Market Dynamics

  • The aging population's preference for procedures with shorter recovery periods and reduced hospitalization costs creates consistent demand across orthopedic, cardiovascular, and gastrointestinal specialties.
  • Government healthcare policies supporting advanced surgical adoption and reimbursement for minimally invasive techniques further accelerate market penetration. Looking ahead to 2030, Japan's market will benefit from increased investment in robotic surgery platforms, enhanced surgeon training programs, and integration of AI-assisted diagnostic tools.
  • The convergence of Japan's manufacturing excellence with healthcare innovation positions the country as a regional hub for minimally invasive surgical device development and export, supporting sustained double-digit growth through the forecast period..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Merck KGaA

    Cardiovascular Devices

    Top Technologies
    • External Defibrillators
    • Implantable Cardioverter Defibrillators
    • Pulse Oximeters
    • Robotic Systems
    • 3-Lead ECG Leadwires
    Top Companies
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Terumo Corporation
    • KONINKLIJKE PHILIPS N.V.

      Diagnostic Imaging

      Top Technologies
      • Magnetic Resonance Imaging (MRI)
      • Computed Tomography (CT)
      • CT Scanners
      • Nuclear Imaging
      • Positron Emission Tomography
      Top Companies
      • Siemens healthineers
      • PHILIPS HEALTHCARE
      • CANON INC.
      • FUJIFILM Holdings Corporation
      • UNITED IMAGING HEALTHCARE CO., LTD.

        Key Takeaways

        • Japan's minimally invasive surgery market will nearly double from USD 5,596.3M (2025) to USD 10,382.2M (2030) at a 13.2% CAGR.
        • Japan's aging demographic and high prevalence of chronic diseases are primary drivers of minimally invasive surgical demand.
        • Japan's advanced healthcare infrastructure and strong reimbursement framework support rapid adoption of innovative surgical technologies.
        • Japan is positioned as a leading Asia Pacific market, with significant investment in surgical training and medical device development through 2030.

        Minimally Invasive Surgery Market Report Scope

        Report Metric Details
        Base Year 2025
        Fastest Growing Segment AMBULATORY SURGERY CENTERS (End User)
        Forecast Period 2025–2030
        Growth Rate CAGR of 16.1% from 2025 to 2030
        Largest Segment HOSPITALS (End User)
        Market Size Base Year (Billions) ~USD 94.48 (2025)
        Revenue Forecast (Billions) ~USD 199.3 (2030)
        Segments Covered Type, Application, End User, Product

        Japan Minimally Invasive Surgery Market Report Segmentation

        4 segment dimensions are covered across the global market.

        By Type

        • Balloon Catheters
        • Balloon Inflation Systems
        • Ct Scanners
        • Dilators
        • Electrocautery Devices
        • Electrosurgical Generators & Accessories
        • Flexible Endoscopes
        • Graspers & Dissectors
        • Guidewires
        • Guiding Catheters
        • Guiding Devices
        • Handheld Instruments
        • Inflation Systems
        • Laparoscopes
        • Laparoscopy Devices
        • Laser Fiber Devices
        • Mri Systems
        • Other Imaging & Visualization Systems
        • Probes
        • Rigid Endoscopes
        • Robotic Instruments
        • Robotic Software & Services
        • Robotic Systems
        • Suturing Instruments
        • Trocars & Cannulas
        • Tubular Retractors
        • Ultrasound Systems
        • X-Ray Systems

        By Application

        • Cardiothoracic Surgery
        • Cosmetic Surgery
        • Dental Surgery
        • Ent & Respiratory Surgery
        • Gastrointestinal & Abdominal Surgery
        • Gynecological Surgery
        • Neurological Surgery
        • Oncological Surgery
        • Orthopedic Surgery
        • Other Surgeries
        • Urological Surgery
        • Vascular Surgery

        By End User

        • Ambulatory Surgery Centers
        • Clinics
        • Emergency & Trauma Centers
        • Hospitals
        • Other End Users

        By Product

        • Electrosurgical Devices
        • Endoscopy Devices
        • Imaging & Visualization Systems
        • Medical Robotics
        • Surgical Devices

        Target Audience

        • Medical Device Manufacturers : Companies developing or marketing minimally invasive surgical instruments, robotic systems, and endoscopic devices need Japan-specific market data to identify growth opportunities, competitive positioning, and regulatory requirements for market entry.
        • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in Japan's healthcare sector require detailed market sizing, growth projections, and competitive dynamics to assess portfolio companies and identify acquisition targets in the MIS space.
        • Hospital & Surgical Center Operators : Japanese healthcare facility administrators need market intelligence on MIS technology trends, reimbursement policies, and patient demand forecasts to guide capital investment decisions and surgical program development.
        • Pharmaceutical & Biotech Companies : Organizations developing adjunctive therapies, imaging agents, or supportive products for minimally invasive procedures require Japan market data to align product development with regional adoption trends and clinical practice patterns.
        • Healthcare Consultants & Analysts : Strategy consultants and market research professionals serving Japanese healthcare clients need comprehensive, Japan-focused MIS market data to support client advisory work, competitive analysis, and strategic planning initiatives.

        Key Companies in the Japan Minimally Invasive Surgery Market

        CompanyHQOwnershipStrongest segments
        BRUKER CORPORATIONUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry, molecular diagnostics, automation, digital),BSI Nano (X-ray, AFM, electron microscopy tools, optical microscopy),
        MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
        JOHNSON & JOHNSONUnited StatesPublic CompanyOncology & Immunology (Innovative Medicine),Neuroscience, Cardiovascular & Metabolism, Infectious Diseases,Surgery & Interventional Solutions (MedTech),
        STRYKERUnited StatesPublic CompanyOrthopaedics Implants (Hip, Knee, Shoulder, Ankle, Trauma & Extremities),MedSurg Equipment & Patient Handling,Neurotechnology & Stroke / VTE Intervention,
        BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, single-use scopes, infection prevention),MedSurg – Urology and Pelvic Health,
        ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
        ZIMMER BIOMETUnited StatesPublic CompanyKnee and Hip Reconstructive Products,S.E.T. (Sports Medicine, Extremities, Trauma, CMF/T),Digital, Robotic, and Enabling Technologies (ROSA, ZBEdge, Bone Cement, Surgical Products),
        GLOBUS MEDICALUnited StatesPublic CompanySpine fusion implants (pedicle screw and rod, plating, interbody, corpectomy),Motion preservation and interventional spine (disc replacement, dynamic stabilization, VCF solutions),Biologic solutions and HCT/P distribution,
        INTEGRA LIFESCIENCES CORPORATIONUnited StatesPublic CompanyCodman Specialty Surgical (neurosurgery and neurocritical care),Tissue Technologies – acute and chronic wound care,Tissue Technologies – surgical reconstruction and nerve/tendon repair,
        SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
        FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, functional films, storage, industrial equipment),Business Innovation (office equipment, document services, graphic communications),
        KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MRI, CT, X-ray, Ultrasound),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory),Image Guided Therapy Systems & Devices,
        GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),

        BRUKER CORPORATION

        Bruker Corporation is a U.S.-based public company founded in 1960 that employs 11,085 people. The company specializes in scientific instruments and analytical solutions.

        MEDTRONIC

        Medtronic is a public company headquartered in Ireland, founded in 1949, with 95,000 employees. It is a global leader in medical technology, services, and solutions.

        JOHNSON & JOHNSON

        Johnson & Johnson is a U.S.-based public company founded in 1886 with 138,200 employees. It operates across pharmaceuticals, medical devices, and consumer health products.

        STRYKER

        Stryker is a U.S. public company founded in 1941 with 56,000 employees. It is a leading provider of medical devices and software for orthopedic, surgical, and neurotechnology markets.

        BOSTON SCIENTIFIC CORPORATION

        Boston Scientific Corporation is a U.S. public company founded in 1979 with 59,000 employees. It develops and manufactures medical devices for interventional medicine and patient monitoring.

        ABBOTT

        Abbott is a U.S. public company founded in 1888 with 115,000 employees. It operates in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.

        ZIMMER BIOMET

        Zimmer Biomet is a U.S. public company founded in 1927 with 17,000 employees. It specializes in orthopedic implants, surgical products, and musculoskeletal healthcare solutions.

        GLOBUS MEDICAL

        Globus Medical is a U.S. public company founded in 2003 with 6,000 employees. It develops and manufactures musculoskeletal implants and surgical instruments.

        INTEGRA LIFESCIENCES CORPORATION

        Integra LifeSciences Corporation is a U.S. public company founded in 1989 with 4,427 employees. It provides surgical implants, instruments, and regenerative medicine products.

        SIEMENS HEALTHINEERS AG

        Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees. It offers diagnostic imaging, laboratory diagnostics, and point-of-care testing solutions.

        FUJIFILM CORPORATION

        Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, information, and document solutions, including healthcare technologies.

        KONINKLIJKE PHILIPS N.V.

        Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees. It provides health technology solutions including diagnostic imaging, patient monitoring, and connected care.

        GE HEALTHCARE

        GE Healthcare is a U.S. public company founded in 2022 with 54,000 employees. It provides medical imaging, monitoring, and diagnostic equipment and software solutions.

        Reasons to Buy this Report

        • Market Size & Growth Validation : Obtain precise market valuation data for Japan (USD 5,596.3M in 2025) with verified 13.2% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making specific to the Japanese market.
        • Competitive Landscape Intelligence : Identify leading Japanese and international MIS device manufacturers, their market share, product portfolios, and strategic positioning within Japan's healthcare ecosystem to benchmark competitive strategies.
        • Demographic & Reimbursement Insights : Understand Japan's aging population dynamics, healthcare policy frameworks, insurance reimbursement rates for minimally invasive procedures, and regulatory pathways that directly impact market opportunities and pricing strategies.
        • Regional Expansion Strategy : Leverage Japan-specific market data to develop targeted go-to-market strategies, identify hospital partnerships, and understand procurement preferences of Japanese healthcare institutions for MIS technologies.
        • Technology Adoption Trends : Access detailed insights on Japan's adoption rates for robotic surgery, AI-assisted diagnostics, and next-generation endoscopic platforms, informing product development and commercialization timelines for the Japanese market.

        Frequently asked questions

        What is the current size of Japan's minimally invasive surgery market?

        Japan's minimally invasive surgery market is valued at USD 5,596.3 million in 2025.

        What is the projected market size for Japan by 2030?

        Japan's minimally invasive surgery market is forecast to reach USD 10,382.2 million by 2030.

        What is the CAGR for Japan's minimally invasive surgery market?

        Japan's minimally invasive surgery market is expected to grow at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2030.

        What factors are driving growth in Japan's minimally invasive surgery market?

        Key growth drivers in Japan include an aging population, rising prevalence of chronic diseases, advanced healthcare infrastructure, strong reimbursement policies, and increasing adoption of innovative surgical technologies.

        How does Japan's market compare to the global minimally invasive surgery market?

        Japan's 13.2% CAGR is slightly below the global average of 16.1%, though Japan represents a significant and mature market within the Asia Pacific region with strong technological adoption.

        RESEARCH METHODOLOGY

        The study involved key activities in estimating the current size of the minimally invasive surgery market. Extensive secondary research was conducted to gather information on the industry. The next step was to validate these findings, assumptions, and market size with industry experts across the value chain through primary research. Different methods, such as top-down and bottom-up approaches, were used to estimate the overall market size. Subsequently, market segmentation and data triangulation techniques were applied to determine the size of various segments and subsegments within the MIS market.

        Secondary Research

        The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global minimally invasive surgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

        Primary Research

        During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from various companies and organizations in the minimally invasive surgery market. On the demand side, primary sources include ambulatory surgical centers, hospitals, clinics, and other end users. The primary research was conducted to validate market segmentation, identify key players, and gather insights on important industry trends and market dynamics.

        A breakdown of the primary respondents is provided below:

        Minimally Invasive Surgery Market

        *C-level primaries include CEOs, CFOs, COOs, and VPs.

        Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

        Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = USD 1.00 billion.

        Source: MarketsandMarkets Analysis

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        For the global market value, annual revenues were estimated based on revenue mapping of leading product manufacturers and OEMs active in the worldwide minimally invasive surgery market. All major product manufacturers were identified at the global and/or country or regional level. Revenue mapping for the respective business segments or sub-segments was performed for the key players. Also, the global minimally invasive surgery market was split into various segments and sub-segments based on:

        • List of major players operating in the product market at the regional and/or country level
        • Product mapping of various minimally invasive surgery manufacturers at the regional and/or country level
        • Mapping of annual revenue generated by listed major players from minimally invasive surgery (or the nearest reported business unit/product category)
        • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
        • Summation of the market value of all segments/subsegments to arrive at the global minimally invasive surgery market

        The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

        Minimally Invasive Surgery Market

        Data Triangulation

        After determining the overall size of the global minimally invasive surgery market using the methodology mentioned above, the market was divided into several segments and subsegments. Data triangulation and market breakdown techniques were used, where applicable, to complete the overall market analysis and obtain precise market value data for the key segments and subsegments. The extrapolated market data was then triangulated by examining various macro indicators and regional trends from both demand- and supply-side participants.

        Market Definition

        Minimally invasive surgery (MIS) is a procedure that causes little to no trauma or injury to a patient. MIS is performed through a cannula using lasers, endoscopes, or laparoscopes. It involves less bleeding, reduced anesthesia, less pain, and minimal scarring compared to other procedures. The surgical instruments used to make tiny incisions and carry out MIS are minimally invasive. The primary products used for minimally invasive surgery are surgical tools, imaging and visualization systems, electrosurgical devices, endoscopy devices, and medical robotics.

        Stakeholders

        • Manufacturers and Distributors of Minimally Invasive Surgical Instruments
        • Healthcare Institutions (Hospitals and Clinics)
        • Ambulatory Surgery Centers (ASCs)
        • Healthcare Institutions (hospitals and outpatient clinics)
        • Research Institutions
        • Research and Consulting Firms
        • Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
        • Academic Medical Centers and Universities
        • Market Research and Consulting Firms
        • Clinical Research Organizations
        • Research Laboratories and Academic Institutes
        • Minimally Invasive Surgical Instrument Service Providers

        Report Objectives

        • To describe, analyze, and forecast the minimally invasive surgery market by product, application, end user, and region
        • To describe and forecast the minimally invasive surgery market in key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
        • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
        • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
        • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
        • To profile key players and comprehensively analyze their market shares and core competencies2 in the minimally invasive surgery market
        • To analyze competitive developments such as partnerships, agreements & acquisitions, product launches, product approvals, and expansions in the minimally invasive surgery market
        • To analyze the impact of AI/Gen AI on the minimally invasive surgery market in terms of its capabilities, potential, use cases, and future

        Available customizations:

        With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

        Geographic Analysis

        • Further breakdown of the Rest of European minimally invasive surgery market into Russia, Switzerland, Denmark, Austria, and others
        • Further breakdown of the Rest of Asia Pacific minimally invasive surgery market into South Korea, Taiwan, and others
        • Further breakdown of the Rest of Latin American minimally invasive surgery market into Argentina, Colombia, Chile, Ecuador, and others
        • Further breakdown of the Southeast Asian minimally invasive surgery market into Malaysia, Singapore, Australia, New Zealand, and others

        Competitive Landscape Assessment

        • Market share analysis, by region (North America and Europe), which provides market shares of the top 3–5 key players in the minimally invasive surgery market
        • Competitive leadership mapping for established players in the US

        Get the Full Minimally Invasive Surgery Market Report

        Full forecast, segment splits, and company analysis for all Minimally Invasive Surgery Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status